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Abstract A single cheating mutant can lead to the invasion and eventual eradication of
cooperation from a population. Consequently, cheat invasion is often considered equal to
extinction in empirical and theoretical studies of cooperator-cheat dynamics. But does cheat
invasion necessarily equate extinction in nature? By following the social dynamics of iron
metabolism in Pseudomonas aeruginosa during cystic fibrosis lung infection, we observed that
individuals evolved to replace cooperation with a ‘private’ behaviour. Phenotypic assays showed
that cooperative iron acquisition frequently was upregulated early in infection, which, however,
increased the risk of cheat invasion. With whole-genome sequencing we showed that if, and only if,
cooperative iron acquisition is lost from the population, a private system was upregulated. The
benefit of upregulation depended on iron availability. These findings highlight the importance of
social dynamics of natural populations and emphasizes the potential impact of past social
interaction on the evolution of private traits.
DOI: https://doi.org/10.7554/eLife.38594.001
Introduction
Identifying mechanisms responsible for the maintenance of cooperation is a major achievement of
evolutionary biology (Axelrod and Hamilton, 1981; Hamilton, 1963). We can predict in which con-
ditions cooperation will thrive, and where it might pay to exploit cooperative neighbours. Evidence
of tension between cooperative and cheating strategies are all around us in nature – for example, in
the co-evolution between flowers and their pollinators (Jande´r and Herre, 2010), the policing and
counter-policing behaviours of social insects (Foster and Ratnieks, 2000) – and in human society
(Mathew and Boyd, 2011; Rand et al., 2011). Cases where these dynamics have resulted in the loss
of cooperation are much less well understood, primarily because long-term consequences of cheat
invasions are unobserved and unreported (Sachs and Simms, 2006). This is for the obvious reason
that it is inherently difficult to detect a history of something that no longer exists. And also because
it is generally the case that once cheating has gone to fixation, it is almost impossible for coopera-
tion to re-invade (Axelrod and Hamilton, 1981). This is where most studies of social dynamics end.
Individuals are nevertheless under selection to survive the loss of cooperation. Consider a popula-
tion where cheating has gone to fixation. If cooperation fulfilled an important function, this popula-
tion may now be at risk of extinction (Fiegna and Velicer, 2003). To escape this fate, selection may
favour individuals that can restore function by employing a ‘privatisation’ strategy – replacement of
a mechanism that was once performed cooperatively as a group, with a selfish one that only benefits
the actor (Bel, 2006). As such, we use the term privatisation as it is normally understood in common
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language to describe a switch in strategy from one that helps a whole group to achieve a goal to
one where a goal is achieved by the actor alone. This differs from its use for describing the acquisi-
tion of property for future benefit by a group or an individual (Strassmann and Queller, 2014), the
retention of public goods for individual use (Asfahl and Schuster, 2017), and for when public goods
only are useable to a part of a community (Niehus et al., 2017). Privatisation could be a common
occurrence in nature that has nevertheless been overlooked because there is no reason, a priori, to
interpret private function as a result of past social interaction. It may also have been missed for the
practical reason that we are required to track behaviour over many generations post-cheat invasion
in a natural population. We overcome these difficulties by studying the evolutionary dynamics of a
cooperative trait for more than an estimated 1.3 million generations (Supplementary file 1A), in a
population of bacterial cells. We report the first observation (to our knowledge) of a natural popula-
tion responding to cheat invasion by adopting a privatisation strategy and, therefore, avoiding the
possibility of extinction.
Our study population is comprised of Pseudomonas aeruginosa bacteria causing lung infection in
patients with cystic fibrosis (CF). CF is a genetic disease that causes the build-up of dehydrated
mucus in lungs and sinuses, which P. aeruginosa infects (Folkesson et al., 2012). The host actively
withholds iron to limit infection, and, as a counter-measure, P. aeruginosa employ a range of differ-
ent iron acquisition strategies (Poole and McKay, 2003). The primary mechanism relies on secretion
of the siderophore pyoverdine (Haas et al., 1991; Konings et al., 2013). This has been demon-
strated to be a cooperative trait, where iron-bound pyoverdine molecules are available for uptake
not only by the producer, but also by neighbouring cells (Buckling et al., 2007; West and Buckling,
2003). P. aeruginosa also make a secondary siderophore, pyochelin, which is cheaper to produce
but has a lower affinity for iron (Dumas et al., 2013). In contrast, the Pseudomonas heme uptake sys-
tem (phu) is private, as the iron-rich compound heme is taken up directly without the secretion of
exploitable exoproducts (Table 1). Additional mechanisms of uptake include the private ferrous iron
transport system (feo; Table 1 [Cartron et al., 2006]), and the heme assimilation system (has). The
has system produces a hemophore that can bind to heme, or hemoglobin that contains heme. In the
closely related system of Serratia marcescens it is conditionally cooperative, as uptake is direct with-
out the hemophore at high concentrations (Ghigo et al., 1997; Le´toffe´ et al., 2004).
P. aeruginosa iron metabolism evolves during long term infection. Pyoverdine production has
repeatedly been found to be lost during CF infection (Andersen et al., 2015; Jeukens et al., 2014;
Konings et al., 2013; Martin et al., 2011), and the phu system has been observed to be upregu-
lated late in infection (Marvig et al., 2014; Nguyen et al., 2014). A major challenge is to identify
the selective pressures experienced in situ that cause such changes. Host adaptation, to accommo-
date for example antibiotic pressure and resource limitations, is frequently predicted to be the
Table 1. Main iron uptake systems of P. aeruginosa.
The pyoverdine and pyochelin systems produce siderophores which can steal Fe3+from host carriers. The conditionally cooperative
has system produces a hemophore that can bind to heme, or hemoglobin that contains heme. The phu and feo systems are private.
All systems have a specific receptor and uptake feeds back to increase system expression. The illustration shows a receptor in the cell
membrane taking up an iron source (star). In a cooperative system a secreted public good (circle) binds the target and is taken up by
the receptor, whereas a private system takes up the iron source directly.
System Mechanism Social status Target Illustration
Pyoverdine Public good; siderophore and specific receptor Cooperative Fe3+,
host-bound
Pyochelin Public good; siderophore and specific receptor Cooperative Fe3+,
host-bound
has Public good; hemophore and specific receptor Conditionally cooperative or private Heme, hemoglobin
phu Specific receptor Private Heme, hemoglobin
feo Specific receptor Private Fe2+
DOI: https://doi.org/10.7554/eLife.38594.002
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primary force in pathogen evolution (Lieberman et al., 2011; Young et al., 2012). Experimentally
recreating host conditions in vitro is challenging, given the complex interplay between spatial struc-
ture, host immunity and nutrient availability (Clevers, 2016), which we are only beginning to be able
to measure (Koo et al., 2011). Clinical measurements may differ from experimental in vivo and in
vitro findings (Cornforth et al., 2018), and studies using ‘simple’ experimental conditions do not
always give comparable results to those that use more complex, and potentially more clinically rele-
vant conditions (Harrison et al., 2017). In contrast, longitudinal sampling of patients to track in situ
evolution provides an opportunity to infer selection without making a priori assumptions about the
experienced environment. Evolutionary theory lets us make testable predictions to distinguish the
effect of host adaptations and social interactions. With this approach we have shown that cheating is
a major selective force in the loss of cooperative iron acquisition in the CF lung (Andersen et al.,
2015).
Here, we identified changes in iron uptake strategies from genome sequences and correlated
these with the social environment (the P. aeruginosa clonal lineage infecting a host), and duration of
infection. Specifically, we test two hypotheses: first, we ask whether an increase in cooperation facili-
tates the breakdown of cooperation in a natural population, and second, can cells survive the loss of
cooperation by switching to a private, and, therefore, unexploitable mechanism for acquiring iron.
Two collections of P. aeruginosa samples were used, covering 551 whole genome sequenced iso-
lates from 64 Danish patients, of 55 clone types (Andersen et al., 2015; Markussen et al., 2014;
Marvig et al., 2013; Marvig et al., 2015; Rau et al., 2012; Yang et al., 2011); allowing for the iden-
tification of patterns of convergent evolution. While the P. aeruginosa populations within patients
are remarkably uniform at the clone type level, colonizers diversify during infection (Mowat et al.,
2011; Winstanley et al., 2016), and lineages may occupy distinct niches at late stages (Jorth et al.,
2015). The isolate collection has been shown to represent the genetic diversity well, with multiple
genotypes co-occurring within individual patient samples (Sommer et al., 2016). A key step in our
analysis is to categorise isolates with respect to their social environment, for example, presence vs
absence of cooperators (pyoverdine producers). This is necessary for testing our hypothesis that iron
acquisition strategy is influenced by the social environment. The likelihood that we do not capture
all co-infecting strains in our sample, for example leading to mis-classification of isolates as belong-
ing to an environment without pyoverdine, will homogenise the sample groups and hence obscure
any differences. Sampling errors of this kind will, therefore, hinder our ability to detect an effect
(Type I error).
Materials and methods
Isolate collections
Two collections of whole genome sequenced P. aeruginosa isolates were used, as described previ-
ously (Andersen et al., 2015). The transmissible clonetypes DK1 (46 isolates) and DK2 (54 isolates)
were sampled from 28 CF patients between 1972 and 2012 (Jelsbak et al., 2007; Markussen et al.,
2014; Marvig et al., 2013; Rau et al., 2012; Yang et al., 2011). Six previously unanalysed DK1 iso-
lates were included (from patients P55M3, P24M2 and P30M0, Supplementary file 1B). Further, 451
isolates of 54 clonetypes from 36 young CF patients were used (the ‘children’s collection’
(Andersen et al., 2015; Marvig et al., 2015), of which 10 were of the DK1 clone type). At each sam-
pling time, 1–8 colonies were cultured from patient sputum, and stored at  80˚ C (Johansen et al.,
2012; Sommer et al., 2016). The sampling regimen for each patient is described in
Supplementary file 1B, and Appendix 1—figures 1 and 2. The two collections complement each
other as one covers a long time period, with relatively few samples from each patient and of both
early and late infection stages, whilst the other covers the first 10 years of infection by environmental
clone types, with more extensive sampling within patients. In the children’s collection there is limited
transmission between patients, but some clone types infect multiple patients, and some patients are
infected by multiple clone types either at the same time or in succession (Marvig et al., 2015). All
but two patients, however, harbour only one dominant clone type at a time and the social environ-
ment is thus made up of clonal lineages sharing the same ancestor. The analysis of increased pyover-
dine production was only performed on the children’s collection, as described below.
Andersen et al. eLife 2018;7:e38594. DOI: https://doi.org/10.7554/eLife.38594 3 of 27
Research article Evolutionary Biology
The phylogeny of the 54 DK2 isolates has previously been reported by Marvig et al. (2013), and
this was adapted for this study to phylogenetically map the order of mutations in regions of interest.
To allow a similar analysis for the DK1 clone type, we used Snippy (Seeman, 2015) to identify SNPs
in each of the 56 DK1 isolates relative to the PAO1 reference genome (RefSeq assembly accession
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Figure 1. Super-cooperators precede the sampling of non-producers. Inverse Kaplan-Meier graph showing that pyoverdine non-producers are found
more often in the presence of super-cooperators (dotted line, n = 25 representing 24 clonal lineages in patients, one of which had two independent
losses of pyoverdine production), compared to when super-cooperators are absent (solid line, n = 22, representing 21 clonal lineages in patients, one
of which had two independent losses). Circles indicate when sampling of clonal lineages stopped, without the observation of lost pyoverdine
production. Insert shows that a transition from wild-type (WT) production to super-cooperation (pvd+) was observed in 24 clonal lineages, followed by
nine independent occurrences of non-producers. Non-producers evolved in the absence of super-cooperators five times. In total, 33 clone types
infecting 35 patients were followed.
DOI: https://doi.org/10.7554/eLife.38594.003
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GCF_000006765.1) and compared the SNPs of all the DK1 isolates to identify those that differed
between the isolates. The SNPs were further filtered to only retain SNPs at positions covered by at
least 10 reads in all isolates and exclude those where all isolates show more than 80% non-reference
reads at the given position. Based on 4,639 SNPs within 2,614,892 sites, a maximum-likelihood phy-
logenetic tree was computed with RAxML version 8.2.11 (Stamatakis, 2014), with default settings
using a general time reversible model of nucleotide substitution (option -m GTRCAT). The tree was
rooted with the PAO1 reference genome.
The length of infection of each clone type in each patient was calculated. Clone types sampled
only once from an individual patient were excluded (23 isolates of 22 clone types). For the transmissi-
ble clone types DK1 and DK2 the total length of infection across patients was used (39 and 36 years,
respectively). This is a very conservative estimate of length of infection, as evolution occurs indepen-
dently in different patients. To calculate the number of generations, a doubling time of 74 min was
used for clonal lineages infecting for less than 6 years, 83 min for 6–24 years and 109 min for >24
years based on the measurements of Yang et al. (2011).
Changes in pyoverdine production during infection
We tested if the appearance of pyoverdine non-producers is correlated with preceding upregulation.
Measurement of pyoverdine production was carried out by fluorescence readings at 400/460 nm
WT pvd- phu+
64% 56%
pch-pch-
24% 22%
11% 11%4% 8%
phu-has-phu- has- pvd-
phu-
Figure 2. Order of mutations across iron acquisition systems. Wild type-like (WT) isolates colonize patients, and
subsequent loss of cooperative pyoverdine production (pvd-) is the most common change in iron metabolism
(n = 25), compared to mutations expected to affect the pyochelin, phu and has systems negatively (pch-, phu-,
has-). Loss of pyoverdine production in clonal lineages is followed by intergenic phuS//phuR mutations, predicted
to upregulate the private phu system, significantly more often than expected by chance (phu+, n = 9). Colour
indicates iron uptake system (green = pyoverdine, yellow = pyochelin, dark red = intergenic phuS//phuR,
orange = phu (either a mix of phuS//phuR and other phu mutations, or only ns SNPs), blue = has). The occurrence
of has mutations may be underestimated due to low sequencing depth of two genes. The figure shows only
transitions where there was a clear order in which systems were affected, see Supplementary file 1F for all
transitions.
DOI: https://doi.org/10.7554/eLife.38594.004
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excitation/emission with a 475 nm cut-off following growth in iron-limited media (Andersen et al.,
2015; Ku¨mmerli et al., 2009). For each clonal lineage the baseline pyoverdine production was
determined as that of the first isolate(s) of a clone type from a patient, and the production of all sub-
sequent isolates of this clone type was compared to this. An isolate was classified as an over-pro-
ducer if its production was >30% higher than that of the first. This cut-off was chosen as ~95% of the
isolates had a lower standard deviation between replicates. The data is available from Dryad
(doi:10.5061/dryad.6963pj3). The analysis was performed on longitudinally sampled clone types
from the children’s collection only, as the DK1 and DK2 isolates were not sampled frequently within
patients. Only non-producers evolved from a clonal lineage that produced pyoverdine at the begin-
ning of the infection period were included. Therefore clone types DK1 (10 isolates, P36F2), DK11
(two isolates, P51M5), DK40 (two isolates, P73M4) and DK53 (10 isolates, P36F2) were excluded
from the analysis, as they were ‘chronic’ clone types with no pyoverdine producers sampled from
the young patients (Appendix 1—figure 1; Andersen et al., 2015). As there were only three sam-
ples from P51M5, this whole patient was excluded from the analyses. In lineages with both over- and
non-producers, over-producers were sampled before non-producers in all but three cases. In two
cases there was <5 months between sampling, and we scored non-producers as occurring at the
same time as overproducers. In one case the non-producer was sampled 2.95 years prior to the
over-producer and scored as having occurred in the absence of an over-producer. The subsequent
sampling of the over-producer, and an additional non-producer that shared the genotype with the
first non-producer, was not included in the analyses (Appendix 1—figure 1, P53M4). In two clone
types two independent transitions to non-producers were observed (non-producing isolates har-
boured different pyoverdine mutations) and these were included as independent events (P44F5 and
P14M4). We focus here on within-clone type dynamics, as temporal overlap of longitudinally sam-
pled clone types only occurred in two patients (Appendix 1—figure 1; Andersen et al., 2015).
We categorized each clone type in individual patients as harbouring over-producers or not. If an
over-producer was present, the length of time from that sampling to a non-producer was observed,
or till the last sample was collected from the patient, was noted. Clone types without non-producers
were classified as right-censored. The same was done for patients without over-producers. In total,
45 clonal lineages were followed covering 404 isolates of 33 clonetypes from 35 patients (Appen-
dix 1—figure 1; some clone types occur in multiple patients, and some patients are infected by mul-
tiple clone types [Marvig et al., 2015]). The timing of sampling of non-producers was analysed with
the ‘survival’ package in R, which takes into account the sampling extent of a clonal lineage, that is
both the timing and frequency of events (R Core Team, 2013; Therneau, 2015).
Identification of mutations in the pyoverdine, pyochelin, phu, has and
feo systems
Mutations in the pyoverdine (pvdQ-pvdI +pvdS pvdG+pvcA ptxR+fpvB), the pyochelin (ampP-
pchA), the phu (prrF1-phuR), the has (PA3404-hasI) and the feo systems (PA4357-feoA) were identi-
fied previously from Illumina GAIIx or HiSeq2000 reads (Andersen et al., 2015; Markussen et al.,
2014; Marvig et al., 2013; Marvig et al., 2015; Rau et al., 2012; Yang et al., 2011)
(Supplementary file 1C-D). Mutations of iron systems in the six new DK1 isolates were identified as
described previously (Andersen et al., 2015), by mapping reads against a DK1 draft genome
(Markussen et al., 2014). Mapping of reads revealed low sequencing depth of the hasD (required
for hemophore secretion) and hasS (the has anti-sigma factor) genes, likely due to repetitive regions.
These were unsuccessfully attempted amplified by PCR. Mutations were categorized as synonymous
(syn) or non-synonymous (ns) SNPs, insertions or deletions (indels), or intergenic. We tested for a
bias in which genes in each operon were mutated with [Poisson test, P(X  changes observed)~Poisson
distribution (pois) (X; changes expected) < 0.05].
We identified the order of mutation across the different iron uptake systems, with a system classi-
fied as mutated by the presence of ns SNPs or indels in any gene in the system. For pyoverdine, the
presence of mutations was compared to the actual measurements of production; the two measures
are highly consistent (Andersen et al., 2015) but when incongruent the phenotype was used. For
the phu region intergenic phuS//phuR mutations predicted to cause receptor upregulation were
included, and when occurring without other phu mutations these were recorded separately. Transi-
tions were identified within clonal lineages, that is if an isolate for example had a pyoverdine muta-
tion and measured loss of production, and a subsequent isolate had the same pyoverdine mutation
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in addition to a pyochelin mutation, this was considered a transition from wild-type (WT) to loss of
pyoverdine, to loss of pyochelin. If for example a phu and pyochelin mutation was observed for the
first time in the same isolate the exact order could not be inferred. In the transmissible clone type
DK2 pyoverdine production was detected to have been lost in an isolate from 1973 and the muta-
tion and phenotype was found in all later isolates. Subsequently, independent clonal lineages for
example accumulate phu mutations. In the analyses this was counted as one loss of pyoverdine, and
then multiple independent phu mutations. We calculated the expected order of mutation, equally
weighted by the size and number of mutations of the different systems. We tested, as described
above, whether this was different from the observed, using only cases where there was a clear order
of mutations. The social environment, that is the genotypes of co-occurring isolates, was not consid-
ered in this analysis.
For the phu system, we located mutations in the phuR receptor gene to functional regions (the
N-terminal-domain, periplasmic turns, transmembrane strands or extracellular loops) using a pre-
dicted structure of the receptor (http://bioinformatics.biol.uoa.gr//PRED-TMBB [Bagos et al.,
2004]). For each domain in the receptor we calculated the expected number of non-synonymous
amino acid changes, as the proportion the domain comprises of the entire protein times the
observed number of changes. Whether the observed changes in each domain differed significantly
from the expected was calculated as described above.
Transitions between public and private iron uptake
To test if the appearance of intergenic phuS//phuR mutations that cause upregulation of the phu
system was correlated with overall loss of pyoverdine production in the social environment we cate-
gorized each independent acquisition of these mutations as having occurred in the presence or
absence of measured pyoverdine production, by the focal isolate and co-occurring isolates. In the
absence of pyoverdine production the time between loss of production and occurrence of mutations
was estimated. The analysis was performed on longitudinally sampled clonal lineages from both col-
lections of isolates, that is lineages with at least two isolates with or without pyoverdine production.
Further, three cases where the loss of pyoverdine production and phuS//phuR mutations were
observed in the same isolate were also included. Clonal lineages that did not acquire phuS//phuR
mutations were classified as right-censored. For DK1 and DK2 we used monophyletic clades with
and without mutations as independent clonal lineages (Blue lines in Appendix 1—figure 3 and
4). Branches with single isolates were not included unless they showed loss of pyoverdine from the
social environment or phuS//phuR mutations (inclusion of these did not significantly affect the result
of the test). We included isolates of DK53 where no WT pyoverdine producer was sampled, but
phuS//phuR mutations were inferred by comparison to PAO1 (Supplementary file 1C).
The phuS//phuR mutations only occurred in isolates that had lost pyoverdine production (Appen-
dix 1—figure 3 and 4). In three instances these, however, co-occurred in the patient with isolates
that produced pyoverdine (Appendix 1—figure 5 and 6). The producers and non-producers with
phu upregulation are unlikely to have interacted at the time when the iron system mutations
occurred in two of these. In patient P30M0, infected with clone type DK1, the cooperating isolates
were sampled from the patient’s sinuses only, while the non-producers with phu upregulation came
from lung samples. In patient P28F1, two lineages of clone type DK1 co-occurred. One had been
transmitted from another patient, where pyoverdine production was lost, and phu likely upregu-
lated, prior to transmission and establishment of a co-infection. In patient P82M3 a pyoverdine pro-
ducer and an isolate with a phuS//phuR mutation, both of clone type DK32, were found in the same
lung sample. The latter harbours the most common phuS//phuR mutation (G 146 upstream//35
upstream A, Supplementary file 1C), which is located outside the phuR promoter (Marvig et al.,
2014). It is the only isolate to have this phuS//phuR mutation in isolation, all others with it have an
additional SNP, and the effect of it is unknown (but see below).
The timing of sampling of mutants was analysed with the ‘survival’ package in R (Therneau, 2015).
We are likely to over-estimate the length of time to mutation, as patients chronically infected with
the transmissible DK1 and DK2 clone types were infrequently sampled (Markussen et al., 2014;
Marvig et al., 2013). In these cases, with several years between longitudinal samples, a mutation
may only be detected years after occurring.
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Uptake of heme following phuS//phuR mutations
We tested if the presence of phuS//phuR mutations gives a growth advantage in iron-limited media
supplemented with heme at different concentrations, using an isogenic pair of DK2 isolates only dif-
fering in the presence of a 1 bp phuS//phuR deletion (Marvig et al., 2014). Three biological repli-
cates of each isolate were cultured in liquid LB media for 24–48 hr, so that all cultures reached an
OD600 above 0.1. Cultures were subsequently standardised to a starting OD600 of 0.001, in iron-lim-
ited CAA media following Ku¨mmerli et al. (2009), without heme or supplemented with 1, 2.5, 5 or
10 mM heme as an iron source (BioXtra porcine hemin 97.0%, Sigma-Aldrich). Of each culture 200
mL were inoculated in 96 well plates. Plates were sealed with a breathable membrane to avoid evap-
oration and incubated in a plate reader measuring OD600 every 30 min for 48 hr. Growth curves
were plotted in Excel and the average maximum OD600 of the three replicates calculated. The differ-
ence in max OD600 between the isolates with and without the phuS//phuR mutation at the various
Figure 3. Loss of cooperation precedes privatisation of iron uptake. Inverse Kaplan-Meier graph showing that phuS//phuR mutations are observed 15
times when pyoverdine is absent from the social environment (solid line, n = 26), and only once when pyoverdine is available in the social environment
(dashed line, n = 47, see text). The mutations are only found in clonal lineages that do not produce pyoverdine. Circles indicate when sampling of
clonal lineages stopped, without the observation of phuS//phuR mutations. Insert shows that a transition from wild-type pyoverdine production (WT) to
no production (pvd-) was observed 22 times in clonal lineages, while phuS//phuR mutations occurred 16 times independently (phu+), 13 of which were
after loss of pyoverdine production from the environment. The order could not be inferred in three cases, in one of which the isolate co-occurred with
pyoverdine producers.
DOI: https://doi.org/10.7554/eLife.38594.005
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heme concentrations was analysed in R with a Two-Way ANOVA test with post hoc comparisons
with Tukey HSD (R Core Team, 2013).
We also compared growth of pairs of clinical isolates with phuS//phuR mutations matched to their
closest genetically related isolate without mutations. The phuS//phuR mutations occurred in three
different clone types without additional phu mutations (DK1, DK2 and DK32, highlighted in yellow in
Supplementary file 1C). Six isolates with mutations were matched with four closest relatives with-
out, because DK2 in two instances had independent phuS//phuR mutations in two closely related
isolates. The WT isolate for these pairs was used to make the isogenic pair described above, and the
mutation of one of these clinical isolates moved to this background (P0M30-1979 and P173-2005;
Appendix 1—figure 7; Marvig et al., 2014). One additional DK2 isolate with a mutation was lost
from the collection, and only available as sequence reads (P80F1; Appendix 1—figure 4 and
Supplementary file 1C). Growth was measured as described above with 2.5 or 5 mM heme as an
iron source, and differences in max OD600 within a pair were compared with a t-test in R (R Core
Team, 2013).
Results and discussion
More cooperative populations are more vulnerable to exploitation
The environmental clones that infect CF patients produce pyoverdine (Andersen et al., 2015) but
what happens as they transition to life in a host? We compared pyoverdine production between iso-
lates sampled at different time points of infection in iron-limited media, in which cells must produce
pyoverdine to avoid iron starvation. In some clonal lineages of P. aeruginosa, defined as longitudi-
nally sampled isolates of the same clone type that share a recent ancestor, pyoverdine production
was maintained for >30 years of CF infection: in the 12 clonal lineages of the transmissible clone
type DK1 that were followed for >30 years there were five independent losses of pyoverdine pro-
duction but three clonal lineages maintained production (Andersen et al., 2015); Appendix 1—fig-
ure 3, and below). Limited diffusion of secreted pyoverdine, as is likely in viscous CF sputum,
impairs the ability of potential cheats to exploit and may contribute to stabilize cooperation in these
lineages (Julou et al., 2013; Kummerli et al., 2009); although there may be significant exchange
between spatially distinct microcolonies (Weigert and Ku¨mmerli, 2017).
When analysing the isolates from 35 frequently sampled young patients of 33 clone types (some
clone types infect multiple patients and some patients harbour multiple clone types), we found that
pyoverdine production increased in 36% of clonal lineages within the first two years of infection.
Overall, these ‘super-cooperator’ isolates, which had >30% higher production than isolates initiating
infection, were detected in 25 of 45 independent clonal lineages (55%; Figure 1), and on average
sampled 1.89 ± 1.79 st. dev. years into the infection. This suggests that upregulation is initially fav-
oured, likely by iron limitation or inter-species competition. In CF patients, P. aeruginosa frequently
co-infects with Staphylococcus aureus (Folkesson et al., 2012), and co-culture in vitro causes an
upregulation of pyoverdine production (Harrison et al., 2008). When in co-infection, iron sequester-
ing can have the additional benefit of making it unavailable for S. aureus or other competitors
(Leinweber et al., 2018; Niehus et al., 2017). Increased production could also be part of a general
acute infection phenotype, as either a pleiotropic side-effect or a beneficial trait (Coggan and Wolf-
gang, 2012). For six out of the 25 lineages with super-cooperators we identified candidate muta-
tions in global regulatory and quorum sensing genes that likely cause increased production of
pyoverdine as well as other virulence factors, such as pyochelin, pyocyanin and alginate
(Supplementary file 1E). For the remainder, super-cooperators produced pyoverdine at a consis-
tently higher rate than their ancestors but the genetic basis of upregulation was unclear.
Despite the potential benefits of pyoverdine production, the presence of super-cooperators
appears to weaken long-term stability of cooperation in the lung. In 12 out of the 35 patients, we
previously observed the appearance of mutants that have lost the ability to synthesise pyoverdine
(Andersen et al., 2015), sampled on average 3.06 ± 2.29 st. dev. years into infection. Here, we
found that the likelihood of these non-producers arising was significantly higher in the presence of
super-cooperators [Survival analysis, c2 (2, N = 47) = 5.7; p < 0.05; Figure 1]. Non-producers were
present in four out of 21 clonal lineages without (19%, on average 2.60 ± 2.45 st. dev years into
infection) and in eight out of 24 lineages (disregarding one where the non-producer was sampled
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prior to the super-cooperator) with super-cooperators (33%, on average 3.32 ± 3.32 st. dev years
into infection and 1.45 ± 1.39 st. dev. years after sampling of a super-cooperator). There was no sig-
nificant difference between the time of sampling of non-producers between lineages with or without
super-cooperators (Welch Two Sample t-test, t =  0.54, df = 8.01, p = 0.61). From the data set it is
not clear whether cheats evolve from super-cooperators or directly from isolates with WT pyoverdine
production, as the genetic basis of over-production is unknown.
Why is upregulation of pyoverdine production associated with the subsequent loss of this trait?
Non-producers appear to be favoured as a result of exploiting the pyoverdine production of neigh-
bouring cells – a strategy referred to as cheating (Ghoul et al., 2014a). We have previously shown
that non-producers in the lung acquire mutations in a pattern consistent with a cheating strategy, as
opposed to one expected from redundancy, in that they retained the pyoverdine receptor only if
producers were present (Andersen et al., 2015). In other words, non-producers lose the capacity to
contribute but retain the ability to benefit from pyoverdine, as long as it is being supplied by coop-
erative neighbours. The relative fitness of cheats is predicted by theory to be greater when there are
higher levels of cooperation in a population, because their competitors are bearing a higher cost
(Ross-Gillespie et al., 2007). This prediction has been shown to hold in empirical tests (Ghoul et al.,
2014b; Harrison et al., 2008; Jiricny et al., 2010). Hence, super-cooperators are predicted to be
especially vulnerable to exploitation and invasion of cheats. While isolates with a WT level of pyover-
dine production may also benefit from the presence of super-cooperators, the larger production
Figure 4. Evolutionary trajectories of iron metabolism in the CF airways. Following infection (n = 45 clonal lineages of 33 clone types), pyoverdine
production is frequently upregulated (n = 25). Cheaters are significantly more likely to invade following upregulation. Following loss of pyoverdine
production in the social environment (n = 26 non-producing clonal lineages of 6 clone types, from eight independent losses of production and two
clonal lineages from which no pyoverdine producers were sampled), the phu system is frequently upregulated by intergenic phuS//phuR mutations (15
times), while this very rarely occurs (one time) when pyoverdine is produced in the social environment (n = 47 producing clonal lineages of 32 clone
types).
DOI: https://doi.org/10.7554/eLife.38594.006
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cost differential between non-producers and super-cooperators gives non-producers a greater
advantage than WT producers. The pattern of upregulation, followed by loss, is likely to be applica-
ble to the evolution of other exoproducts during infection.
Evolution of iron acquisition systems in the lung – the sequence of
events
How do the changes in cooperative pyoverdine production relate to the overall iron metabolism of
the cells? Comparison of the accumulation of mutations across five different iron uptake systems
(Table 1) and measurement of pyoverdine production showed that the appearance of pyoverdine
non-producers is the first change in iron metabolism observed in most clonal lineages, in both isolate
collections. Loss-of-function of the cooperative pyoverdine system occurred earliest in 16 out of 25
clonal lineages where the phenotypic measurements and sequence analysis provided a clear order
of systems affected (Figure 2; Supplementary file 1F). These were observed to occur on average
3.06 years after the first sampling of the clone type in the young patients (n = 11 clonal lineages in
nine patients), and between 1–39 years after infection for the more rarely sampled transmissible
clone types (n = 5 clonal lineages in five patients). When weighed by the high mutation rate of the
system, reflecting a strong selection pressure, and its large size, this is not unexpected [Poisson test,
P(X  16) ~ pois (X; 14.69) > 0.05), Figure 2; Supplementary file 1D].
Mutation of the cooperative pyochelin system first was found not to differ from that expected
given a random distribution of mutations [Poisson test, P(X  6) ~ pois (X; 5.14) > 0.05), Figure 2;
Supplementary file 1D]. The conditionally private or cooperative has heme uptake system was
found to acquire few mutations during infection. It remains to be tested if this is because mainte-
nance of the system is favoured by selection, or if selection for loss is relatively weak. The private feo
system is rarely mutated (Supplementary file 1D) and has been suggested to be of increased impor-
tance as conditions turn microanaerobic during infection (Hunter et al., 2013).
Across both isolate collections we observed pyoverdine cheats appear 14 times without going to
fixation within the patient during the sampling period, but further recorded eight cases where no
producers were sampled a year prior to, or after emergence a non-producer, and two clonal lineages
from where no producers are sampled at any point. This is the potential extinction scenario of cheat
invasion. However, because we have continued to sample after this event, we can observe how the
population responds to this potentially catastrophic situation. One of these events for
example occurred in the transmitted clone type DK2 that was subsequently sampled from 16
patients over 35 years. And because cheat invasion is not inevitable, we can compare dynamics in
lungs with and without availability of pyoverdine.
Cheat invasion is associated with a subsequent switch to private iron
uptake mechanism
After cooperation was lost from a clonal lineage, and only if it was lost, we observed that iron uptake
was privatised (Figure 3). This was achieved by upregulation of the private phu system. The phu sys-
tem targets the iron-rich heme molecule, which is taken up directly through a membrane-bound
receptor PhuR (Table 1; Ochsner et al., 2000). Increased expression of the phu system results from
intergenic mutations between the phuS gene encoding a heme traffic protein, and the receptor
gene phuR (phuS//phuR mutations; Marvig et al., 2014). In the isolate collections, a total of 29
SNPs and two indels accumulate in the phuS//phuR region. Eight of these mutations in the phuR
promoter have been found to cause a significant upregulation of promoter activity, and one of these
has further been shown, in an isogenic pair, to provide a growth benefit to the carrier when heme is
available as an iron source (Marvig et al., 2014); see also below). These specific mutations were
found to arise significantly more frequently than expected by chance following the loss of pyover-
dine production [Poisson test, P(X  5) ~ pois (X; 0.39) < 0.01); Figure 2]. In three patients, non-pro-
ducing isolates with phuS//phuR mutations were sampled at the same time as pyoverdine
producers, however in two of these the producer and non-producers were unlikely to interact, and in
the third the phuS//phuR mutation occurred outside the phu promoter region with unknown effects
on heme uptake (but see Appendix 1—figure 7). We thus conclude that phu upregulation takes
place when pyoverdine production is lost from the social environment. Many of the isolates with
phuS//phuR mutations also harboured pyoverdine receptor mutations that eliminate the possibility
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to cheat (6 out of 7 in DK1, 7 out of 7 in DK2, 1 out of 2 in DK53, 0 out of 1 in DK32; Appendix 1—
figure 3–6; Andersen et al., 2015). Knock-out of the pyoverdine receptor is, however, not expected
to be a selective force in phu upregulation. Rather, the data suggest that both occur because pyo-
verdine is no longer available in the environment, selecting for privatisation of iron uptake and elimi-
nation of the costly receptor (Andersen et al., 2015).
Social interactions are unlikely to be the only selection pressure influencing dynamics in iron
acquisition strategies. Changes in iron uptake strategy might more readily be expected to reflect
changes in the lung environment as the availability of iron in different forms increases with disease
progression (Hunter et al., 2013). And while iron is found to be equally available in its oxidized fer-
ric (Fe3+) and reduced ferrous forms (Fe2+) in early infection, there is a skew towards the reduced
form later, which the feo system targets (Hunter et al., 2013). Heme and hemoglobin are also pres-
ent in the sputum (Ghio et al., 2013), and availability has been speculated to increase as the lung tis-
sue degrades (Marvig et al., 2014), as evidenced by increased coughing up of blood, termed
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Figure 5. Effect of phu upregulation depends on the heme concentration. An isogenic pair of isolates differing
only in a 1 bp phuS//phuR deletion was grown in iron-limited media supplemented with heme at 1–10 mM. The
clinical isolate without the mutation, that does not produce pyoverdine (WT), had a significant higher maximum
OD600 after 48 hr growth at 5 and 10 mM, whereas the mutant (phu+) grew best at 2.5 mM. There was no significant
difference at 1 mM. Boxplots show median value, and the interquartile range ±25%. The * marks a significant
difference at p < 0.05.
DOI: https://doi.org/10.7554/eLife.38594.007
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hemoptysis, with age (Thompson et al., 2015). As such, pyoverdine may be most efficient early in
infection, and phu only advantageous later as lung tissue degrades and/or alternative sources of iron
become more or less abundant. However, the patterns we observe are not consistent with this
explanation. If pyoverdine production is maintained, the phuS//phuR genotype remains unaltered
from colonization, even after more than 30 years of infection (Figure 3). The phuS//phuR mutations,
responsible for upregulating the private phu system, are only observed in non-producers, and in 15
out of 16 cases after the loss of cooperation in the population [Survival analysis, c2 (2,
N = 73) = 11.7; p < 0.01; Figures 3 and 4], occurring between 0 to 35 years after the loss of pyover-
dine production. Upregulation of private iron uptake can, therefore, be predicted from the social
environment, not duration of infection and associated changes in the lung environment.
Why is private heme uptake only upregulated if cooperation is lost?
The fact that we only observe upregulation of the phu system if pyoverdine production has been lost
suggests that privatisation is not universally beneficial but may instead represent a final recourse
when other mechanisms are no longer functioning. P. aeruginosa iron uptake is finely controlled by
feedback loops, in response to environmental iron concentrations and need (Vasil and Ochsner,
1999). As iron is toxic at high concentrations (Anzaldi and Skaar, 2010; Touati, 2000), an indiscrimi-
nate upregulation of one system could be a significant disadvantage in environments where iron
concentrations fluctuate. We, therefore, tested whether the growth benefits of phu upregulation (by
phuS//phuR mutations) were dependent on iron availability, in the form of heme which the phu sys-
tem targets. We examined the growth difference between a clinical isolate that had lost pyoverdine
production, and an isolate, isogenic but for a clinical phuS//phuR mutation that cause an upregula-
tion of the heme receptor gene phuR (Marvig et al., 2014). The experiment was performed in iron-
limited media supplemented with heme at biologically relevant concentrations, which ranged
from <1 mM typical of healthy individuals, across 2.5 mM, 5 mM to 10 mM typical of CF patients
(Ghio et al., 2013).
Consistent with our hypothesis, we find that phu upregulation is only beneficial at a narrow range
of intermediate heme concentrations. There was a significant growth difference between the isolates
and heme concentrations, and an interaction effect (Two-Way ANOVA; Interaction term: Isolate*-
Heme: F = 48.11, df = 3, p < 0.01; Figure 5; Supplementary file 1G). At 2.5 mM heme the isolate
with an upregulated phu system achieved a higher density (Tukey HSD, padj <0.01, Figure 5), consis-
tent with previous findings (Marvig et al., 2014). In contrast, at 5 and 10 mM the isolate without
upregulation had an advantage (padj <0.05, Figure 5). No growth was observed in the absence of
heme, and at 1 mM there was no significant difference in growth between the isolates but a trend for
the WT to do better (padj = 0.073). This suggests that phuS//phuR mutations lead to increased heme
uptake that is beneficial at low external concentrations (>1 and<5 mM heme) but detrimental at high
concentrations (>5 mM heme). Analyses of pairs of clinical isolates with and without phuS//phuR
mutations gave less clear results, but showed a similar pattern of a benefit of phuS//phuR mutations
at low concentrations of added heme (Appendix 1—figure 7). If iron availability increases during
infection, an initially beneficial upregulation of heme uptake would turn toxic. In the phu system we
found a significant bias towards mutations of the phu receptor gene phuR (Poisson test, P(X  24) ~
pois (X; 10.69) < 0.05; Supplementary file 1D). These were not randomly distributed but primarily
found in the extracellular loops of the phu receptor, that initiate the uptake of heme (Noinaj et al.,
2010; Smith et al., 2015) [Poisson test, P(X  15)~pois (X; 7.28) < 0.05; Figure 6]. If there is selec-
tion to reduce iron concentration within cells, these may, therefore, represent compensatory
mutations.
Conclusions
Bacterial cells will be under selection to adapt to the host environment, including antibiotic pressure
(Lieberman et al., 2011). The observations we report here, however, demonstrate the errors of
interpretation that can arise from assuming that bacterial cells are driven entirely by the evolutionary
imperative to survive in the host. As in all other organisms, fitness is also determined by the ability
to compete with members of the same species, and these two evolutionary drivers – host adaptation
and competition – do not always coincide. Our results show that the initial upregulation of coopera-
tion, selected by either the environmental conditions, competition or as a pleiotropic side-effect,
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facilitates cheating. The subsequent privatisation of iron uptake is a response to the loss of coopera-
tion, not simply an adaptation to iron availability in the host as previously suggested (Marvig et al.,
2014), and as we show this carries its own costs. The effect of the social environment on iron acquisi-
tion mechanism remains statistically detectable despite the noise from variation in patient age, sex,
infection and treatment. In a clinical system like this, failure to appreciate these factors can lead to
misinterpretation of how bacterial cells are influenced by the host environment and, therefore,
impair necessary understanding for the development of intervention strategies (Leggett et al.,
2014).
Evolutionary theory clearly predicts that any adaptation involving cooperation can be vulnerable
to exploitation, irrespective of its benefits (Axelrod and Hamilton, 1981). But this is often over-
looked when it is difficult to characterize the selective environment, as for example, inside a human
host. By longitudinal sampling of bacterial populations, we were able to observe the consequences
of cheat invasion for an essential trait and show that switching to a private strategy can provide bac-
terial cells with an evolutionary alternative. This observation highlights the importance of considering
potential constraints imposed by social interactions: if a private trait is expressed it may not be the
most efficient in a given environment, but simply the final recourse in a population with a history of
exploitation.
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Figure 6. Distribution of non-synonymous mutations in the PhuR heme receptor. The figure shows the b-barrel
structure spanning the cell membrane (horizontal lines) with transmembrane strands (grey bars), extracellular loops
(labelled L1-L11) and periplasmic turns (bottom loops). Green circles indicate the location of non-synonymous
SNPs, the smallest circles denoting one mutation and the largest four. Mutations were significantly biased towards
the extracellular loops.
DOI: https://doi.org/10.7554/eLife.38594.008
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Additional files
Supplementary files
. Supplementary file 1. Tables with Supplementary Information. (A) Calculation of estimated genera-
tion times of infecting clone types. For each, the patient ID, clone type, length of infection in years
and minutes, estimated doubling time and calculated number of generations is given. A doubling
time of 74 min was used for clonal lineages infecting for less than 6 years, 83 min for 6–24 years and
109 min for >24 years based on the measurements of Yang et al. (2011). This is, to our knowledge,
the best available for CF conditions. (B) Overview of patients and isolates. For each patient is given
the ID, the number of samples, the year of first sample, the extent of sampling in years, whether
pyoverdine non-producers were sampled, the number of clone types sampled, and the clone type
name(s). (C) List of mutations in genes associated with iron metabolism. For each isolate, the patient
ID, clone type and mutations are listed. A //denotes an intergenic mutation. The isolate names refer
to previous descriptions (Andersen et al., 2015; Markussen et al., 2014; Marvig et al., 2015). The
six DK1 isolates that were not included in the previous analysis of pyoverdine mutations had one ns
SNP in pvdL (A5702G) and one in pvdP (C1508T, patient P55M3, isolate TM50 and TM51). The six
isolates used in the phenotypic assay of phuS//phuR mutations are highlighted in yellow. (D) Sum-
mary of the mutations found in five different iron uptake systems in P. aeruginosa. The size of the
respective systems is given in kb, and mutations are listed as non-synonymous (ns) SNPs, synony-
mous (syn) SNPs, insertions and deletions (indels) and intergenic (IG). The overall mutations, and ns
SNPS and indels, per kb are listed. The phu operon experienced the highest mutation rate, domi-
nated by intergenic mutations. Two genes in the has operon were poorly sequenced in the majority
of isolates, and this is taken into account in the size and mutations listed in parentheses. (E) Muta-
tions identified in pyoverdine over-producers that may contribute to this phenotype. For each muta-
tion, the patient ID, clone type and gene is listed, as well as a reference to previous work showing a
link between the gene and pyoverdine production (Frangipani et al., 2014; Ochsner et al., 2002;
Stintzi et al., 1998; Visaggio et al., 2015; Wu et al., 2004). (F) Transitions between iron uptake sys-
tems characterized as the order in which mutations accumulate. When a clear order of mutations
could be established the observed and expected number of transitions, given a Poisson distribution,
is stated and whether the difference between them is statistically significant. (G) Results of Tukey
HSD post hoc comparison of a Two-Way ANOVA analysing the difference in Max OD600 between an
isogenic pair of isolates differing in a phuS//phuR mutation at four different heme concentrations.
DOI: https://doi.org/10.7554/eLife.38594.009
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Data availability
Pyoverdine reads are available on Dryad at DOI: https://doi.org/10.5061/dryad.6963pj3, and were
used to identify isolates with increased pyoverdine production, as presented in Appendix 1-Fig. 1
and Fig. 1. Sequencing data is previously published and available from GenBank. The mutation lists
for the isolates from the Children’s collection from Marvig et al., 2015, can be downloaded from
https://www.nature.com/articles/ng.3148#supplementary-information. The mutation list for the
transmissible clone type DK1 from Markussen et al., 2014, can be downloaded from https://mbio.
asm.org/content/mbio/5/5/e01592-14/DC1/embed/inline-supplementary-material-1.pdf. The muta-
tion lists for the transmissible clone type DK2 from Marvig et al., 2013, can be downloaded from
https://doi.org/10.1371/journal.pgen.1003741.s009 and https://doi.org/10.1371/journal.pgen.
1003741.s010. Datasets S03 and S04 from Andersen et al, 2015, with lists of mutations in the pyover-
dine system, are downloadable from http://www.pnas.org/content/112/34/10756/tab-figures-data#-
fig-data-tables. The raw reads and mutation lists were used to identify mutations in five iron uptake
systems, as presented in Supplementary Table 1C and D. Table S03 from Yang et al., 2011, is down-
loadable from http://www.pnas.org/content/108/18/7481/tab-figures-data, and was used to esti-
mate the number of generations that Pseudomonas aeruginosa was followed for in cystic fibrosis
patients.
The following dataset was generated:
Database and
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2015 Convergent evolution and
adaptation of Pseudomonas
aeruginosa within patients with
cystic fibrosis
https://www.ncbi.nlm.
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Sequence Read
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Rau MH, Marvig RL,
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adaptation of Pseudomonas
aeruginosa toa human host
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Appendix 1
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The sampling regimen behind the two isolate collections.
We used two collections of P. aeruginosa isolates to study iron metabolism during CF
infection. For the ‘children’s’ collection the young patients have been sampled frequently, for
up to 10 years, and that the majority are infected with unique environmental clone types.
When P. aeruginosa was found to transmit between CF patients (Cheng et al., 1996;
Jelsbak et al., 2007), care was taken to avoid that younger patients become infected with
adapted clone types in the clinic. In the collections we use this is clear as the children’s
collection encompass 54 clone types while the collection of isolates from adults contain only
two, highly transmissible, clone types. This collection covers >30 years. To give an overview of
the sampling regimen we present first an overview of isolates sampled from the individual
patients (Appendix 1—figures 1 and 2). To further illustrate how the DK1 and DK2 evolve and
transmit between patients we present phylogenies of the two transmissible clone types with
the primary changes in iron metabolism in the pyoverdine and phu systems highlighted
(Appendix 1—figures 3 and 4).
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Appendix 1—figure 1. Sampling regimen and standardised pyoverdine production of
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longitudinally sampled clonal lineages (>1 isolate) from the children’s collection. Plots show the
sampling time of isolates from individual patients denoted by the patient code and clone type.
When more than one clone type was sampled they are ordered so that the first listed
corresponds to the dot symbol, followed by the square and triangle. The y-axis shows
pyoverdine production standardized by production of the first sampled isolate(s). Isolates with
a production of 10–129% of the WT are green, non-producers with a production at <10% of
the WT are red, and super-cooperators with a production >130% of the WT are blue. Dashed
red lines mark these cut-off points. Four clonal lineages of a ‘chronic’ phenotype with no
pyoverdine producers sampled were excluded from the analysis on super-cooperators (DK1
and DK53 in P36F2, DK40 in P73M4, and DK11 in P51M5). When sampling is shown to start
later than year 0 (as e.g. for P67M4) there was a sample collected earlier from the patient that
either was not sequenced or of a clone type only sampled once. Created with ggplot2 in R
(R Core Team, 2013; Wickham, 2016).
DOI: https://doi.org/10.7554/eLife.38594.012
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Appendix 1—figure 2. Sampling regimen for the transmissible clone types DK1 and DK2. On
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the x-axis is sampling year and on the y-axis the patient ID. Red dots show DK1 and blue DK2.
Dot size reflects the number of samples collected in a given year (1-4). Note that patient
P36F2 from the children’s collection is included here as this patient harboured DK1 in addition
to two other clone types (see also Appendix 1—figures 1 and 6). Created with ggplot2 in R
(R Core Team, 2013; Wickham, 2016).
DOI: https://doi.org/10.7554/eLife.38594.013
Appendix 1—figure 3. Phylogenetic tree of DK1 samples. Tree was generated as described in
Methods. Patient ID is denoted by shape and sampling year is listed. When multiple samples
were collected from the same patient the same year, they are labelled corresponding to labels
used in Supplementary file 1C. Scale depends on branch thickness; the thickest branch is only
used for samples from P36F2. A green empty circle shows the loss of pyoverdine production
measured phenotypically. A green circle with a cross shows the occurrence of a non-
synonymous mutation in the pyoverdine receptor gene fpvA or the receptor sigma-factor gene
fpvI. A full red circle shows phuS//phuR mutations, a red circle with a cross non-synonymous
mutations in the phu receptor gene phuR and an empty red circle additional non-synonymous
phu mutations. Additional mutations in the pyoverdine, pyochelin, has and feo systems are not
shown. Blue lines mark monophyletic clades used in the analysis on phu upregulation. For
isolates from P36F2, one phuR mutation, and three in fpvA were found in multiple isolates on
polyphyletic branches (marked with 1, 2 and 3). These are likely not independent, and were
not treated as such. Differences in pyoverdine mutations between isolates from P36F2 and
P46F0 and P28F1 suggest two independent losses of production..
DOI: https://doi.org/10.7554/eLife.38594.014
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Appendix 1—figure 4. Phylogenetic tree of DK2 samples, adapted from (Marvig et al., 2013).
Pheno- and genotypes highlighted as in Appendix 1—figure 3.
DOI: https://doi.org/10.7554/eLife.38594.015
To clarify the within-patient dynamics and social environment we provide an overview of
the phenotypes of isolates for the 11 patients with DK1 and DK2 that were sampled
longitudinally (Appendix 1—figure 5). There are two patients (P28F1 and P30F0) where DK1
isolates that have lost pyoverdine production and have phu upregulated are sampled
concurrently with WT pyoverdine producers. In P30F0 the isolates with phu upregulation were
isolated from the sinuses, and the rest from the lungs, and these have therefore inhabited
different niches. In P28F1, the pyoverdine and phu mutations occurred in another patient
(likely P46F0, Appendix 1—figure 3) and were transmitted to patient P28F1 where another
DK1 lineage also established. In three patients DK1 and DK2 overlapped in time (P24M2,
P43M2 and P73F1, Appendix 1—figure 5). Could the two clone types have interacted, in
regards to iron uptake, in these three patients? Patient P73F1 was first found to be colonized
by DK2 in 1984, which had already lost pyoverdine production and uptake ability in 1973
(Appendix 1—figure 4). In the last two isolates there were two independent upregulations of
the phu system (Appendix 1-fig. 4 and 5). A DK1 isolate was sampled in 2002 that also had
pyoverdine production and uptake knocked-out, and carried phuS//phuR mutations for phu
upregulation. From the DK1 phylogeny (Appendix 1—figure 3) it is unclear whether these
mutations in DK1 occurred in patient P73F1 and were transmitted to patient P43M2 or vice
versa. Given the simultaneous upregulation of phu in DK2 in P73F1 we speculate that they
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may have occurred in this patient. In patient P24M2 a WT-like DK1 clonal lineage is sampled
over a timespan of nine years co-occurring with the non-cooperative and non-cheating DK2.
The young patient P82M3 was infected by clone type DK32, and three of the late isolates had
lost pyoverdine production (Appendix 1—figure 6). Two of these, co-occurring with
pyoverdine producers, had a phuS//phuR mutation outside of the phuR promoter, as
discussed in the main text. Patient P36F2 was first infected by DK53 and DK1, neither of which
produced pyoverdine and DK53 further had phuS//phuR mutations. A WT- like pyoverdine
producer, DK15, was later sampled (Appendix 1—figures 1 and 6).
Appendix 1—figure 5. Phenotypes of longitudinally sampled DK1 and DK2 lineages. Size of
circle denotes the number of samples (1-3). WT-like isolates that produce pyoverdine are
shown as a full green circle, non-producers in white with a green stroke, pyoverdine receptor
mutations with a green cross and phu-upregulation by phuS//phuR mutations is shown with
red. Created with ggplot2 in R (R Core Team, 2013; Wickham, 2016).
DOI: https://doi.org/10.7554/eLife.38594.016
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Appendix 1—figure 6. Phenotypes of co-occurring clone types in two patients from the child-
ren’s collection. Phenotypes as in Appendix 1—figure 5. Size of circle denotes the number of
samples (1, 2 and 4). On the x-axis years since colonization. Note that patient P36F2 is shown
in both Appendix 1—figures 5 and 6.
DOI: https://doi.org/10.7554/eLife.38594.017
Growth effect of phuS//phuR mutations in clinical
isolates.
We tested if the phuS//phuR mutations are beneficial in the clinical isolates, using six isolates
of three different clone types that had acquired a variety of phuS//phuR mutations, and no
additional phu mutations (Supplementary file 1C, marked in yellow). We compared fitness of
the mutants with their closest genetically related isolate without phuS//phuR mutations. The
isolates in a pair were, however, separated by numerous other mutations as they were
sampled up to 26 years apart. The pairs were grown in iron-limited media with 2.5 and 5 mM
heme added. Three mutants with intergenic SNPs had significantly higher (P73F1; 26% higher;
t =  6.33, df = 3.48, p > 0.01 and P83M2; 16% higher, t =  4.48, df = 2.15, p < 0.05; isolates
sampled 0 and 23 years apart) or a non-significant tendency towards a higher maximum OD600
in 5 mM heme compared to their closest relative (P66F0; 17% higher, t =  2.85, df = 2.67,
p = 0.07; isolates sampled 10 years apart; Appendix 1—figure 7). A mutant with a three bp
insertion, and an isolate with a one base pair deletion in phuS//phuR in addition to a SNP,
showed no significant difference in growth compared to their closest relative (17% higher,
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t =  1.78, df = 2.95, p = 0.18; 16% lower, t = - 0.55, df = 2.56, p = 0.10; isolates sampled 3
and 26 years apart; Appendix 1—figure 7). These two isolates have, however, previously
been shown to have respectively 25 and 116 fold increased expression of the phu receptor
compared to the wild type (Marvig et al., 2014; Yang et al., 2011), and transfer of the one
base pair deletion to its ancestor confirms that it infers growth benefits in heme media
(Marvig et al., 2014; Figure 5). This suggest that other mutations across the genome affect
the phenotype we are interested in, which is not unexpected given that we are comparing
isolates sampled years apart, and the complex genome of P. aeruginosa where almost 10% of
the genes are predicted to be regulatory (Stover et al., 2000). There were no significant
growth differences with 2.5 mM heme added. Both isolates of the sixth pair, with a SNP, grew
very slowly in rich LB media, and not at all in iron-limited media with or without heme. It is not
clear why the beneficial effect of heme in these isolates is seen at a higher concentration
compared to the isogenic pair (5 mM vs 2.5 mM, Figure 5).
Appendix 1—figure 7. Growth of pairs of clinical isolates with and without phuS//phuR muta-
tions. Isolates were grown in iron-limited media with 5 mM heme added. Pairs where the same
WT isolate is used because of two independent acquisitions of phuS//phuR mutations are
highlighted in red and blue. Boxplots show median value of three biological replicates, and
the interquartile range ±25%. * marks a significant difference. Plotted in R (R Core Team,
2013; Wickham, 2016).
DOI: https://doi.org/10.7554/eLife.38594.018
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